As the expenses associated with new product development (NPD) continue to rise, intellectual capital (IC) plays a critical yet understudied role in influencing NPD performance (NPDP). To address this, we present a comprehensive theoretical framework to empirically analyze how IC provides pharmaceutical companies with essential capabilities to enhance NPDP through the perspective of organizational learning (OL). This study employs a multi-source, time-lagged, and survey-based approach to gather relevant data from pharmaceutical companies. The findings reveal positive relationships between IC components—human, structural, and relational capital— and OL. Moreover, OL emerges as a pivotal predictor of the link between IC components and NPDP. Notably, we uncover that the association between OL and NPDP is moderated by the presence of an innovation culture within organizations. This research significantly contributes to the existing literature by providing new empirical insights into the strategic role of IC in promoting the creation and dissemination of new knowledge within organizations. These insights have substantial implications for practitioners and academics by bolstering firms' capacity for NPDP in knowledge-based sectors.

中文翻译：

---

推动新产品开发绩效：智力资本前因和创新文化的调节作用


随着与新产品开发 (NPD) 相关的费用持续上升，智力资本 (IC) 在影响 NPD 绩效 (NPDP) 方面发挥着关键但尚未得到充分研究的作用。为了解决这个问题，我们提出了一个全面的理论框架，从组织学习（OL）的角度实证分析 IC 如何为制药公司提供增强 NPDP 的基本能力。本研究采用多源、时滞、基于调查的方法从制药公司收集相关数据。研究结果揭示了 IC 组成部分（人力资本、结构资本和关系资本）与 OL 之间的正相关关系。此外，OL 成为 IC 元件和 NPDP 之间联系的关键预测因子。值得注意的是，我们发现 OL 和 NPDP 之间的关联受到组织内创新文化的调节。这项研究对 IC 在促进组织内新知识的创造和传播方面的战略作用提供了新的实证见解，对现有文献做出了重大贡献。这些见解通过增强企业在知识型领域的 NPDP 能力，对从业者和学者产生重大影响。